SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC). A UK randomised phase III trial

被引：0
|
作者：
Landau, D. B. [1 ]
Hughes, L. [2 ,3 ]
Ngai, Y. [2 ,3 ]
Hanna, G. G. [4 ]
Conibear, J. [5 ]
Farrelly, L. [2 ,3 ]
Counsell, N. [2 ,3 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, Oncol, EH, London, England
[2] CRUK, London, England
[3] UCL Canc Trials Ctr, Inst Canc, TJ, London, England
[4] Queens Univ Belfast, Ctr Canc Res & Cell Biol, AE, Belfast, Antrim, North Ireland
[5] St Bartholomews Hosp, Barts Canc Inst, BE, London, England
来源：
LUNG CANCER | 2017年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
119
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [1] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC): a randomised phase III trial
    McDonald, F.
    Mak, K. M.
    Teague, J.
    Landau, D.
    Hanna, G.
    Farrelly, L.
    Counsell, N.
    [J]. LUNG CANCER, 2020, 139 : S91 - S91
  • [2] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer (NSCLC). A UK Randomized Phase III Trial
    Ngai, Yenting
    Hanna, Gerard
    Conibear, John
    Counsell, Nicholas
    Hughes, Laura
    Farrelly, Laura
    Landau, David
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1425 - S1426
  • [3] SARON: stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer (NSCLC)
    Mak, Ka-Man
    McDonald, Fiona
    Teague, Jonathan
    Faivre-Finn, Corinne
    Forster, Martin
    Hanna, Gerard
    Moinuddin, Syed
    Conibear, John
    Harden, Susan
    Popat, Sanjay
    Califano, Raffaele
    Farrelly, Laura
    Counsell, Nicholas
    Saron, T. M. G.
    [J]. LUNG CANCER, 2022, 165 : S71 - S71
  • [4] Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer
    Conibear, John
    Chia, Brendan
    Ngai, Yenting
    Bates, Andrew Tom
    Counsell, Nicholas
    Patel, Rushil
    Eaton, David
    Faivre-Finn, Corinne
    Fenwick, John
    Forster, Martin
    Hanna, Gerard G.
    Harden, Susan
    Mayles, Philip
    Moinuddin, Syed
    Landau, David
    [J]. BMJ OPEN, 2018, 8 (04):
  • [5] Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 21 - 24
  • [6] Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy
    Dohopolski, Michael
    Iyengar, Puneeth
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (05) : 5944 - 5953
  • [7] Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer (vol 8, e020690, 2018)
    Conibear, John
    Chia, Brendan
    Ngai, Yenting
    Bates, Andrew Tom
    Counsell, Nicholas
    Patel, Rushil
    Eaton, David
    Faivre-Finn, Corinne
    Fenwick, John
    Forster, Martin
    Hanna, Gerard G.
    Harden, Susan
    Mayles, Philip
    Moinuddin, Syed
    Landau, David
    Franks, Kevin
    Ahmed, Merina
    Harrow, Stephen
    Mendes, Ruheena
    Hatfield, Paul
    Tsang, Yat Man
    Mak, Ka Man
    Farrelly, Laura
    Conibear, John
    Chia, Brendan
    Ngai, Yenting
    Bates, Andrew Tom
    Counsell, Nicholas
    Patel, Rushil
    Eaton, David
    Faivre-Finn, Corinne
    Fenwick, John
    Forster, Martin
    Hanna, Gerard G.
    Harden, Susan
    Mayles, Philip
    Moinuddin, Syed
    Landau, David
    [J]. BMJ OPEN, 2019, 9 (05):
  • [8] Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer
    Ricardi, Umberto
    Levra, Niccolo Giaj
    Badellino, Serena
    Alongi, Filippo
    [J]. JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2235 - 2237
  • [9] Local ablative radiotherapy for oligometastatic non-small cell lung cancer
    Suh, Yang-Gun
    Cho, Jaeho
    [J]. RADIATION ONCOLOGY JOURNAL, 2019, 37 (03): : 149 - 155
  • [10] CyberKnife stereotactic ablative radiotherapy (SABR) in patients with non-small cell lung cancer ( NSCLC)
    Leschenko, Y.
    Chebotareva, T.
    Spizhenko, N.
    Fedusenko, A.
    Sharaevskiy, O.
    Buryk, V.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S39 - S39
12345